pharma · Retinitis Pigmentosa · Dry Eye Disease · KPRX
KIORA PHARMACEUTICALS
KIORA PHARMACEUTICALS INC
Kiora Pharmaceuticals is a pharma organization headquartered in Encinitas, USA. It trades on NYSE under ticker KPRX. Primary therapeutic focus areas include Retinitis Pigmentosa, Dry Eye Disease, Macular Edema, Persisten
Encinitas, USA HQ
2013 Founded
18 Employees
Public company Type
KPRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Encinitas, USA
- Founded
- 2013
- Employees
- 18
- Programs
- 5
- Drugs
- 4
- Patents
- 4
KIO-301
Phase 2 · small molecule · Retinitis Pigmentosa
KIO-301 for Retinitis Pigmentosa is a Phase 2 program (small_molecule) at KIORA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Internal code KIO-301-1101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- KIORA PHARMACEUTICALS INC
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Retinitis Pigmentosa
- Status
- completed
- Trials
- 1